These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 456460)

  • 1. Schistosoma mansoni: complement and cercarial tail loss during in vitro transformation.
    Greenblatt HC; Eveland LK; Morse SI
    Exp Parasitol; 1979 Aug; 48(1):100-8. PubMed ID: 456460
    [No Abstract]   [Full Text] [Related]  

  • 2. Schistosoma mansoni: role in vivo of complement in primary infection of mice.
    Santoro F; Vandemeulebroucke B; Liebart MC; Capron A
    Exp Parasitol; 1982 Aug; 54(1):40-6. PubMed ID: 7095075
    [No Abstract]   [Full Text] [Related]  

  • 3. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
    Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
    Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: a complement-dependent receptor on adult male parasites.
    McGuinness TB; Kemp WM
    Exp Parasitol; 1981 Apr; 51(2):236-42. PubMed ID: 6781918
    [No Abstract]   [Full Text] [Related]  

  • 5. Schistosoma mansoni: complement activation in human and rodent sera by living parasites of various developmental stages.
    Ruppel A; Rother U; Vongerichten H; Diesfeld HJ
    Parasitology; 1983 Aug; 87 (Pt 1)():75-86. PubMed ID: 6604899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
    Santoro F; Lachmann PJ; Capron A; Capron M
    J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
    [No Abstract]   [Full Text] [Related]  

  • 9. Schistosoma mansoni: ultrastructural damages due to complement on schistosomula in vitro.
    Ouaissi MA; Santoro F; Capron A
    Exp Parasitol; 1980 Aug; 50(1):74-82. PubMed ID: 7389860
    [No Abstract]   [Full Text] [Related]  

  • 10. Schistosoma mansoni: activation of the alternative pathway of human complement by schistosomula.
    Dias Da Silva W; Kasatchkine MD
    Exp Parasitol; 1980 Oct; 50(2):278-86. PubMed ID: 7409076
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternate complement pathway in porcine sera: lysis of guinea pig erythrocytes.
    Renshaw HW; Gilmore RJ
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):473-84. PubMed ID: 7471719
    [No Abstract]   [Full Text] [Related]  

  • 12. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 13. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative measurement of C3 activation at polymer surfaces.
    Herzlinger GA; Bing DH; Stein R; Cumming RD
    Blood; 1981 Apr; 57(4):764-70. PubMed ID: 7470626
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
    Doherty M; Whicher JT; Dieppe PA
    Ann Rheum Dis; 1983 Jun; 42(3):285-91. PubMed ID: 6407405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 18. Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula.
    Wang W; Kirschfink M; Ruppel A
    Parasitol Res; 2006 Aug; 99(3):269-74. PubMed ID: 16547731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni.
    Marikovsky M; Parizade M; Arnon R; Fishelson Z
    Eur J Immunol; 1990 Jan; 20(1):221-7. PubMed ID: 2307175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
    van Dam AP; Hack CE
    Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.